Pediatrics Doctors in Yreka, CA Accepting Medicare

3 Pediatrics doctors found. Showing 1 - 3

Dr. David Earl Marriott, MD Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 444 Bruce St, Yreka, CA 96097 Phone: 530-842-4121

Dr. Vina K Swenson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 1501 S Oregon St, Yreka, CA 96097 Phone: 530-842-2062    Fax: 530-842-2160

William F Broeckel, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 475 Bruce St, Yreka, CA 96097 Phone: 530-841-4980    Fax: 530-841-4979

News Archive

Study provides insight into developing new treatment strategies for triple-negative breast cancer

A new study by University of Kentucky researchers provides insight into developing new treatment strategies for basal-like breast cancer, commonly known as triple-negative breast cancer. This cancer is associated with early metastasis and resistance to chemotherapy and occurs at women at a younger age.

Mother's sleep can impact health of their growing baby, shows research

How much sleep mothers get when they are pregnant can impact on the health of their growing baby, according to a new scoping study conducted by the University of South Australia.

DaVita Kidney Care recognizes June as National Men's Health Month

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, recognizes the month of June as National Men's Health Month and the importance of bringing awareness to the health care issues that affect men.

Children exposed to cigarette smoke may have lesser response to asthma treatment

Children exposed to cigarette smoke at home have lower levels of an enzyme that helps them respond to asthma treatment, a study has found.

Added benefit of ipilimumab in advanced melanoma not proven for non-pretreated patients

The German Institute for Quality and Efficiency in Health Care already assessed the added benefit of ipilimumab in advanced melanoma in 2012. A considerable added benefit was found for patients who had already received previous treatment. In the new dossier compiled by the drug manufacturer, the drug was now compared with the appropriate comparator therapy dacarbazine specified by the Federal Joint Committee (G-BA) also for non-pretreated patients.

Read more Medical News

› Verified 8 days ago